Skip Ribbon Commands
Skip to main content
Menu
Dr Sumbul Zaheer

Dr Sumbul Zaheer

​MBBS, MRCP(UK), FAMS

Senior Consultant

Singapore General Hospital

Specialty: Nuclear Medicine and Molecular Imaging

Conditions Treated by this Doctor:
Bone Mineral Densitometry (BMD), General Nuclear Medicine, Liver Tumours, Neuroendocrine Tumors, Nuclear Cardiology, Nuclear Oncology, PET/CT, Prostate Cancer, Radionuclide Bone Pain Palliation, Radiosynovectomy, Thyroid Cancer, Thyrotoxicosis, Y90 Microspheres.

Clinical Appointments

  • Senior Consultant Nuclear Medicine and Molecular Imaging Singapore General HospitalSingapore General Hospital

Academic Appointments

  • Site Director, Endocrine residency programs of other hospitals in Singapore
  • Clinical faculty, SingHealth Nuclear Medicine and Radiolgy Residency Program
  • Adjunct Assistant Professor

Profile

Dr Zaheer trained in Internal Medicine in UK and underwent Advanced Specialist Training in Nuclear Medicine in Singapore (2007-2009). She is a Member of the Royal College of Physicians UK, and a Fellow of the Academy of Medicine, Singapore. 

In addition to her clinical duties she has contributed to Education and Research in Nuclear Medicine. She was core faculty of the inaugural Nuclear Medicine Senior Residency program in Singapore from 2013 to 2020. She has authored / contributed to peer-review journal articles and a book chapter on thyroid cancer and is part of ongoing research trials.  

Education

  • Membership Royal College of Physicians (UK)
  • MBBS (Jawaharlal Nehru Medical College, AMU, India)

Professional Appointments and Committee Memberships

  • Clinical faculty, Singhealth Nuclear Medicine and Radiolgy Residency Program
  • Adjunct Assistant Professor, Duke-NUS Medical School
  • Fellow of the Academy of Medicine, Singapore 
  • Site Director of the Endocrine residency programs of other hospitals in Singapore
  • Team leader for the department’s QI initiatives 

Awards

  • National Healthcare Group Outstanding Education Partners Award (2021)
  • SingHealth 10-year long-service award (2018)
  • Outstanding Faculty Award, Residency in SingHealth Excels (RiSE) Award, 2013-14
  • University medals for academic excellence at medical school (1996)

Research Interests

Publications

  1.  KSH Loke, WY Tham, P Bharadwaj, FYJ Keng, Z Huang, MB Idu,Yen Ming Wong, Paul Kia Siong Tan, Sumbul Zaheer et al. Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT). Journal of Nuclear Cardiology 27 (3), 1005-1009
  2. CYL Tang, WM Chua, LTJ Cheng, W Fong, S Zaheer, WWC Lam-18F-FDG PET/CT Manifestations of IgG4-related Disease. The British journal of radiology 94 (1124), 20210105
  3. Osmany S, Zaheer S, Bartel TB, Johnston M, Peh WM, Barmaky S, Jadvar H. Gallium-68-Labeled Prostate-Specific Membrane Antigen-11 PET/CT of Prostate and Nonprostate Cancers. AJR Am J Roentgenol. 2019 Aug;213(2):286-299. doi: 10.2214/AJR.19.21084. Epub 2019 Jun 5.
  4. Al Tamimi AS, Zaheer S, Ng DC, Osmany S. (18)F-Fluorodeoxyglucose-positron Emission Tomography/Computed Tomography Imaging of Metastatic Nasopharyngeal Cancer with Emphasis on the Distribution of Bone Metastases. World J Nucl Med.2017 Jul-Sep;16(3):192-196. doi: 10.4103/1450-1147.207273. PubMed PMID: 28670176;
    PubMed Central PMCID: PMC5460301.
  5. Tong AK, Zhang ZX, Zaheer S, Yan XS. Dual-phase (18)F-fluorocholine PET/CT to detect locoregional recurrence of prostate cancer: comparison between each time point of imaging and a summation scan. Clin Imaging. 2016 May-Jun;40(3):486-91.doi: 10.1016/j.clinimag.2015.12.010. Epub 2016 Jan 6. PubMed PMID: 27133692.
  6. Kao YH, Gan HK, Zaheer S, Lam WW, Loke KS, Wong WY, Ng DC, Goh AS. Gender, Race, and Age at Diagnosis as Risk Factors for Metastasis or Recurrence among1,657 Thyroid Cancer Patients Treated with Radioiodine across 40 Years in Singapore. Oncol Res Treat. 2015;38(12):679-82. doi: 10.1159/000442114. Epub 2015Nov 18. PubMed PMID: 26633801.
  7. Al Tamimi AS, Zaheer S, Ng DC, Osmany S. The incidence and sites of Nasopharyngeal carcinoma (NPC) metastases on FDG PET/CT scans. Oral Oncol. 2015Nov;51(11):1047-1050. doi: 10.1016/j.oraloncology.2015.08.001. Epub 2015 Aug 24. PubMed PMID: 26315255.
  8. Zaheer S, Tan A, Ang ES, Loke KS, Kao YH, Goh A, Wong WY. Post-thyroidectomy neck ultrasonography in patients with thyroid cancer and a review of the literature. Singapore Med J. 2014 Apr;55(4):177-82,; quiz 183. Review. PubMed PMID: 24763832; PubMed Central PMCID: PMC4291944.
  9. Al-Tamimi A, Zaheer S, Pierce CK, Osmany S, Sittampalam K. Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT). Sultan Qaboos Univ Med J. 2012 Aug;12(3):371-4. Epub 2012 Jul 15. PubMed PMID: 23269951; PubMed Central PMCID: PMC3529665.
  10. Lim TC, Tan EH, Zaheer S, Use of Ga-68 DOTATATE PET/CT to confirm portal vein tumor thrombosis in a patient with pancreatic neuroendocrine tumor. Clin Nucl Med. 2011 Jun;36(6):498-9. doi: 10.1097/RLU.0b013e318217398b. PubMed PMID:21552039.
  11. Zaheer S, Osmany S, Lai HK, Eng DN. Usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a case of choriocarcinoma presenting as pulmonary embolism. Clin Nucl Med. 2009 Jun;34(6):343-5. doi:10.1097/RLU.0b013e3181a34634. PubMed PMID: 19487841

TRIALS
  • A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of novel anti-hormonal therapy (NAH) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of NAH
  • Somatostatin receptor imaging in Nasopharyngeal cancer, Epstein-Barr Virus related cancers and other rare tumors
  • Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer


Research Trials